Skip to main content
. 2016 Jan 4;2016(1):CD006995. doi: 10.1002/14651858.CD006995.pub2

3.11. Analysis.

3.11

Comparison 3 Any antiglucocorticoid versus placebo as adjunct to combination treatment, Outcome 11 Global state: 2a. Specific ‐ positive symptoms ‐ no clinically significant improvement ‐ data only for mifepristone (< 50% improvement BPRS, PSS).